Who has invested in Day One Biopharmaceuticals?

No investors are named on the public record for Day One Biopharmaceuticals yet.

Day One Biopharmaceuticals Funding: $374M Raised, IPO (2021)

Day One Biopharmaceuticals funding overview

Day One Biopharmaceuticals has raised $374M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in May 2021. The round record for Day One Biopharmaceuticals runs through 2021; nothing later has been disclosed.

Day One Biopharmaceuticals at a glance

Total raised: $374M
Latest round: IPO
Latest round date: May 2021

Frequently asked about Day One Biopharmaceuticals funding

How much has Day One Biopharmaceuticals raised?: Day One Biopharmaceuticals has raised $374M in total disclosed funding across the rounds on record.
Who has invested in Day One Biopharmaceuticals?: No investors are named on the public record for Day One Biopharmaceuticals yet.
What was the latest Day One Biopharmaceuticals funding round?: The most recent disclosed round is an IPO, announced in May 2021.
Where is Day One Biopharmaceuticals based?: No headquarters location is disclosed for Day One Biopharmaceuticals.
When did Day One Biopharmaceuticals last raise?: The last disclosed Day One Biopharmaceuticals round closed in May 2021 at IPO.

Totals shown for Day One Biopharmaceuticals aggregate every disclosed round on file. To see how that compares, browse the companies and the investors behind them below.

Day One Biopharmaceuticals Funding: $374M Raised, IPO (2021)

Day One Biopharmaceuticals funding overview

Day One Biopharmaceuticals at a glance

Frequently asked about Day One Biopharmaceuticals funding

Companies related to Day One Biopharmaceuticals (30)

Browse related funding lists (3)